Technologies
#UT-001 Our new, patent protected, preeclampsia (PE) prognosis method relies on a panel of at least four biomarkers, which concentrations in maternal blood serum are simultaneously measured in a single test tube, and at least one clinical cofactor. With our method, it is now possible to predict the development of PE or the absence...
Technologies
#UT-001 Our new method of selection of embryos suitable for uterine transfer and implantation relies on We have discovered specific RNA transcripts which expression level in endometrial cell lines (responder cells) are indicative of the embryo quality and allow to establish an implantation prognosis. In vitro fertilization (IVF), is the most common and...